Table 1.
Treatment goals for glycemia (% of patients to targets)
| ADA | IDF | AACE | |
|---|---|---|---|
| A1c(%) | <7.0 | <6.5 | <6.5 |
| FPG(mg/dL) | 80–120 | <100 | <110 |
| 2-h PPG(mg/dL) | <180 | <135 | <140 |
ADA 2006: “The A1c goal for the individual patient is an A1c as close to normal (<6%) as possible without significant hypoglycemia”.
Sources: ADA 2006. Standards of medical care in diabetes – 2006. Diabetes Care, 29(Suppl 1):S4-S42; AACE 2002. American College of Endocrinology. Medical guidelines for the management of diabetes mellitus: The AACE system of intensive diabetes self-management – 2002 update. Endocr Pract, 8(Suppl 1):40–82; IDF. 1999. A desktop guide to type 2 diabetes mellitus. European Diabetes Policy Group 1999. Diabet Med, 16:716–30.
Abbreviations: AACE, American Association of Clinical Endocrinologists; ADA, American Diabetes Association; FPG, fasting plasma glucose; IDF, International Diabetes Federation; PPG, postprandial glucose.